Sou Hu Cai Jing·2026-02-27 19:30Group 1 - The core point of the article highlights that southbound funds have increased their holdings in Chunli Medical (01858.HK) by 168,200 shares on February 27, with a total net increase of 152,000 shares over the last five trading days [1] - Over the past 20 trading days, southbound funds have reduced their holdings in Chunli Medical for 12 days, resulting in a cumulative net reduction of 1,129,700 shares [1] - As of now, southbound funds hold 41,216,800 shares of Chunli Medical, accounting for 43.31% of the company's total issued ordinary shares [1] Group 2 - Chunli Medical is primarily engaged in the research, production, and sales of implantable orthopedic medical devices in China [1] - The company's main products include joint prosthetics, spinal implants, trauma products, sports medicine products, platelet-rich plasma (PRP) products, oral products, and surgical robots [1] - The joint prosthetics product line covers four major human joints: hip, knee, shoulder, and elbow, with products sold in both domestic and international markets [1]